August 24, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Statin discontinuation, compared with continued use, did not raise all-cause mortality over 3 years among adults aged at least 75 years who were taking statins for primary prevention of atherosclerotic cardiovascular disease.For older adults on statin therapy for primary prevention of ASCVD, discontinuation of statin therapy conferred similar adverse event rates and quality of life scores vs.
August 24, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Discontinuation was not linked to changes in quality of life, symptom burden, or adverse events

Stopping statins in people over 75 at low risk for heart disease didn’t increase deaths, a new study finds.

French scientists found that older adults who hadn't suffered a heart attack or stroke previously were not significantly more…

Up to 21.5 million additional U.S. adults may be considered eligible for statin therapy based on newly updated dyslipidemia…

SCOTTSDALE, Ariz. — Contrary to guidelines, one in three eligible patients with new-onset diabetes do not receive a prescription…

The results, in The Lancet journal, come from trials involving more than 120,000 people comparing statins with a dummy drug or…